Biasucci, Luigi Marzio
 Distribuzione geografica
Continente #
EU - Europa 4.093
NA - Nord America 3.404
AS - Asia 1.232
AF - Africa 28
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 8.786
Nazione #
US - Stati Uniti d'America 3.382
DE - Germania 1.914
SE - Svezia 698
CN - Cina 638
UA - Ucraina 376
IT - Italia 349
SG - Singapore 311
IE - Irlanda 168
FR - Francia 158
GB - Regno Unito 153
ID - Indonesia 105
RU - Federazione Russa 83
FI - Finlandia 79
TR - Turchia 67
IN - India 55
AT - Austria 25
BE - Belgio 25
CI - Costa d'Avorio 22
JP - Giappone 17
CA - Canada 16
PL - Polonia 16
IR - Iran 11
NL - Olanda 9
HK - Hong Kong 8
AU - Australia 7
GR - Grecia 6
CH - Svizzera 5
CL - Cile 5
EU - Europa 5
LT - Lituania 5
PT - Portogallo 5
BR - Brasile 4
CZ - Repubblica Ceca 4
ES - Italia 4
MX - Messico 4
IL - Israele 3
LK - Sri Lanka 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
MY - Malesia 2
OM - Oman 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BZ - Belize 1
EC - Ecuador 1
EE - Estonia 1
IQ - Iraq 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
TW - Taiwan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 8.786
Città #
Chandler 783
Ashburn 253
Jacksonville 241
Singapore 240
Nanjing 201
San Mateo 188
Dublin 166
New York 154
Wilmington 112
Nürnberg 106
Jakarta 105
Ann Arbor 103
Nanchang 85
Boston 77
Dearborn 74
Houston 68
Cattolica 66
Milan 65
Marseille 64
Lawrence 60
Izmir 59
Moscow 57
Woodbridge 57
Munich 51
Redwood City 47
Bremen 41
Princeton 38
Seattle 38
Hangzhou 33
Kunming 33
Los Angeles 28
Shenyang 26
Fairfield 25
Tianjin 25
Beijing 24
Brussels 24
Vienna 23
Abidjan 22
Changsha 21
Leawood 21
Boardman 20
London 20
Hebei 18
University Park 18
Jiaxing 17
Mountain View 17
Rome 17
Zhengzhou 17
Augusta 16
Fremont 16
Kraków 15
Lancaster 15
Norwalk 15
Shanghai 15
Washington 13
Detroit 12
Enterprise 12
Chicago 11
Andover 9
Toronto 9
Changchun 8
Falls Church 8
Kish 8
Simi Valley 8
Bielefeld 7
Costa Mesa 7
Saint Louis 7
San Jose 7
Hefei 6
Helsinki 6
Lanzhou 6
Mumbai 6
Ningbo 6
Pune 6
Santa Clara 6
Anzio 5
Ferrara 5
Guangzhou 5
Jinan 5
Old Bridge 5
Paris 5
Redmond 5
Cambridge 4
Fuzhou 4
Hong Kong 4
Indiana 4
Orange 4
San Diego 4
Tokyo 4
Wuhan 4
Berlin 3
Busto Arsizio 3
Castignano 3
Colombo 3
Frankfurt am Main 3
Las Vegas 3
Ottawa 3
Padova 3
Phoenix 3
San Francisco 3
Totale 4.405
Nome #
Paradoxical preservation of vascular function in severe obesity 280
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 201
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes 193
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 182
Predictors of Postoperative Atrial Fibrillation in Patients with Coronary Artery Disease Undergoing Cardiopulmonary Bypass: A Possible Role for Myocardial Ischemia and Atrial Inflammation 175
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 160
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability 159
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 152
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation 151
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 147
Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients 144
Endothelial progenitor cells in morbid obesity 143
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 137
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 133
Thromboxane production in morbidly obese subjects 133
High telomerase activity in neutrophils from unstable coronary plaques 132
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 131
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 128
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment 126
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 123
Pioglitazone reduces monocyte activation in type 2 diabetes 123
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 122
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 117
Sex-related differences in myocardial remodeling 117
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 113
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 112
Hypersensitivity myocarditis or Kounis syndrome? 112
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 106
Identification of unique adaptive immune system signature in acute coronary syndromes 106
Increased PTPN22 Expression and Defective CREB Activation Impair Regulatory T-Cell Differentiation in Non-ST-Segment Elevation Acute Coronary Syndromes 106
Ethanol abolishes ischemic preconditioning in humans 105
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 104
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 103
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 103
Serum levels of γ-glutamyltransferase and progression of coronary atherosclerosis 103
Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: Pathogenetic implications 101
Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes 100
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 93
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 93
Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered T-cell differentiation in Non-ST segment elevation acute coronary syndrome 90
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells 90
Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome 89
Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. 88
Microparticles and microRNAs: new players in the complex field of coagulation 88
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 87
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 85
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 84
Prognostic biomarkers in ST-segment elevation myocardial infarction: a step toward personalized medicine or a tool in search of an application? 82
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 82
Microparticles in health and disease: small mediators, large role? 82
Inflammatory markers in STelevation acute myocardial infarction 79
Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? 78
Associations between the Framingham Risk Score and coronary plaque characteristics as assessed by three-vessel optical coherence tomography 76
Healed Plaques in Patients With Stable Angina Pectoris 74
Biomarkers of inflammation and endothelial function: the holy grail of experimental and clinical medicine? 73
A case of unusual acute coronary syndrome. 73
Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study 71
Platelet microRNAs are not modulated by systemic heparin in acute coronary syndromes 71
Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study 71
Prognostic biomarkers in ST-segment elevation myocardial infarction: a step toward personalized medicine or a tool in search of an application? 68
Platelet microRNAs are not modulated by systemic heparin in acute coronary syndromes 67
Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited 66
Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study 64
Between Death and Hope After Out-of-Hospital Cardiac Arrest: Should We Rely on Biomarkers? 64
Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease 62
Evolocumab and clinical outcomes in patients with cardiovascular disease 60
Potential therapeutic role of microRNAs in ischemic heart disease 59
Where Does Inflammation Fit? 59
Biomarkers of inflammation and endothelial function: the holy grail of experimental and clinical medicine? 59
Comparative safety and effectiveness of coronary computed tomography: Systematic review and meta-analysis including 11 randomized controlled trials and 19,957 patients 57
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 57
Has atorvastatin more than a DUAAL face? 56
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment 56
Superficial calcified nodules and post-stenting micro-dissections imaged through 3-dimensional optical coherence tomography 55
Inflammatory markers in ST-elevation acute myocardial infarction 53
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 53
MicroRNA and myocardial infarction: a mystery turning into glory? 52
Endothelial Shear Stress and Coronary Plaque Characteristics in Humans: A Combined Frequency-Domain Optical Coherence Tomography and Computational Fluid Dynamics Study 51
Prevalence and Predictors of Multiple Coronary Plaque Ruptures: In Vivo 3-Vessel Optical Coherence Tomography Imaging Study 50
Promises and challenges of targeting inflammation to treat cardiovascular disease: the post-CANTOS era 48
Response by Russo et al Regarding Article, "healed Plaques in Patients with Stable Angina Pectoris" 48
Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography 45
Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study 45
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden. 44
Evaluation of culprit lesions by optical coherence tomography in patients with ST-elevation myocardial infarction 44
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction 43
Role of the central autonomic nervous system intrinsic functional organisation and psychosocial factors in primary microvascular angina and Takotsubo syndrome 43
Innate immune inflammatory response to danger: when, how, and why does a friend become a foe? 42
Targeting inflammation: Impact on atherothrombosis 40
The Role of the Central Autonomic Nervous System and Psychosocial Factors in Microvascular Angina and Takotsubo Syndrome 40
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 40
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis 39
Inflammation as a possible link between coronary and carotid plaque instability 39
Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression 38
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 37
Bivalirudin versus unfractionated heparin for residual thrombus burden: A frequency-domain optical coherence tomography study 37
Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis 30
How to use C-reactive protein in acute coronary care 27
The 'open-artery hypothesis': New clinical and pathophysiologic insights 25
Totale 8.852
Categoria #
all - tutte 34.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020689 0 0 0 0 92 98 125 30 98 41 103 102
2020/2021685 20 76 10 79 95 42 88 21 108 25 106 15
2021/20221.052 50 72 17 41 62 31 25 196 39 107 200 212
2022/20232.128 310 320 190 307 139 233 126 173 218 49 51 12
2023/2024905 43 261 29 34 27 187 35 58 5 18 99 109
2024/2025479 51 65 134 93 136 0 0 0 0 0 0 0
Totale 8.922